As per our latest research, the global kidney cancer drugs market size in 2024 stands at USD 6.2 billion, reflecting robust demand driven by the rising incidence of renal malignancies and increasing adoption of advanced therapeutics. The market is anticipated to expand at a CAGR of 6.4% during the forecast period, reaching a projected value of USD 10.8 billion by 2033.
https://growthmarketreports.co....m/report/kidney-canc